Latest Regulatory News

Page 24 of 798
Zenith Minerals (ASX: ZNC) has commenced an eight-hole reverse circulation drilling program at its Consolidated Dulcie Gold Project, aiming to grow and enhance its recently defined 675,000 ounce inferred gold resource. The campaign targets near-resource zones and strategic gaps along a 6 km mineralised corridor, while regional exploration efforts continue.
Maxwell Dee
Maxwell Dee
8 Apr 2026
AuMEGA Metals Limited has launched a prospectus for a dual-tranche capital raising totalling approximately C$23.7 million, subject to shareholder approval, aimed at advancing its exploration programs in Newfoundland and Labrador, Canada.
Maxwell Dee
Maxwell Dee
8 Apr 2026
BlackRock Investment Management (Australia) Limited has released estimated cash distributions for multiple Australian domiciled iShares ETFs, alongside key dates and investor instructions for the April 2026 distribution period.
Claire Turing
Claire Turing
7 Apr 2026
Kali Metals Limited (ASX:KM1) has finalised its Tranche 2 Placement, issuing 527,778 shares at A$0.18 each and raising approximately A$95,000 following shareholder approval.
Maxwell Dee
Maxwell Dee
7 Apr 2026
Key Petroleum Ltd (ASX:KEY) has completed a placement of over 3 million shares, raising approximately AUD 176,660 before costs to fund asset acquisitions, development, and working capital.
Maxwell Dee
Maxwell Dee
7 Apr 2026
Octava Minerals (ASX:OCT) has completed its acquisition of the Byro Critical Minerals Project in Western Australia, issuing over 8.5 million shares and 2 million performance rights to vendors, subject to escrow and milestone conditions.
Maxwell Dee
Maxwell Dee
7 Apr 2026
National Storage REIT (ASX:NSR) has confirmed satisfaction of key foreign investment conditions for its proposed acquisition by a Brookfield-GIC consortium, with securityholder meetings scheduled for mid-April.
Eva Park
Eva Park
7 Apr 2026
Archer Materials has progressed its Biochip program by completing the alpha prototype and Stage 1 project with IMEC, now advancing to develop a beta prototype suitable for external use and clinical validation.
Sophie Babbage
Sophie Babbage
7 Apr 2026
Mesoblast Limited (ASX:MSB, Nasdaq:MESO) reported net sales of US$30.3 million for its FDA-approved cellular therapy Ryoncil in the March quarter, bringing total revenue since launch close to US$100 million. Strong sales in February and March offset January’s seasonal dip.
Ada Torres
Ada Torres
7 Apr 2026
Memphasys Limited (ASX: MEM) announced an investor webinar and released an updated presentation detailing its transition from early-stage commercialisation to scaling global revenues, highlighting multi-market sales, recurring cartridge revenue, and regulatory progress.
Ada Torres
Ada Torres
7 Apr 2026
Energy Transition Minerals Ltd (ASX:ETM) has obtained Foreign Direct Investment approval from the Spanish Government, a key regulatory milestone enabling the completion of its acquisition of the Penouta Tin-Tantalum Mine in Spain. The company anticipates finalising the acquisition this quarter, pending mining licence transfers.
Maxwell Dee
Maxwell Dee
7 Apr 2026
Xenitra Limited (ASX:XEN) has introduced the OPAL Token and Xen Shop, a blockchain-based digital commerce ecosystem aimed at improving product authentication, customer loyalty, and sales transparency across its Asian FMCG markets.
Victor Sage
Victor Sage
7 Apr 2026